Document is current

Any future updates will be listed below

Correction: Phase 1b study of first-line fuzuloparib combined with modified FOLFIRINOX followed by fuzuloparib maintenance monotherapy in pancreatic adenocarcinoma

Crossref DOI link: https://doi.org/10.1186/s12916-025-04078-y

Published Online: 2025-04-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark